ArticleKidney3602020
Global Dialysis Perspective: Japan.
Article in Kidney360, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Economics of drug-coated balloons for arteriovenous fistula stenosis in Japan and Korea based on the IN.PACT AV access trial.Nephrology (Carlton, Vic.) · 2022Trial
- Survival in haemodialysis has improved considerably in Okinawa, Japan (1971-2020).Clinical kidney journal · 2026Article
- Recent trends in dialysis initiation in Japan: a region‑specific descriptive analysis using Hokkaido as an example.Clinical and experimental nephrology · 2026Article
- First-time diagnosis and referral practices for individuals with CKD by primary care physicians: a study of electronic medical records across multiple clinics in Japan.Clinical and experimental nephrology · 2025Observational
- Intermittent Infusion Hemodiafiltration: A Narrative Review of an Emerging Dialysis Modality.Toxins · 2025Review
- Self-management interventions for adult haemodialysis patients: a scoping review of randomized controlled trials.BMC nephrology · 2025Article
- Cost-Effectiveness Analysis of SGLT2 Inhibitors for Cardio-Renal-Metabolic Disease Based on Data from Japanese Studies.Advances in therapy · 2025Article
- Chronic Kidney Disease Requiring Hemodialysis as a Significant Predictor of Target Lesion Revascularization After Endovascular Treatment of Femoropopliteal Occlusive Lesions with a Drug-Coated Balloon.Journal of clinical medicine · 2025Article
- Cancer diagnosis and prognosis after initiation of hemodialysis: multicenter Japan CANcer and DialYsis (J-CANDY) study.Clinical kidney journal · 2025Article
- One-year Survival of End-Stage Kidney Disease Patients Undergoing Hemodialysis in Indonesia.International journal of nephrology and renovascular disease · 2025Article
- Article
- Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan.Advances in therapy · 2024Article
- A Case of Drug-Resistant Myoclonus Improved by Only Slight Adjustment to the Hemodialysis Setting.Cureus · 2023Article
- Prefecture-specific prevalence of overweight/obesity is associated with regional variation in the incidence of treated ESKD in Japan.Clinical and experimental nephrology · 2023Article
- The Etiology of Kidney Failure in Indonesia: A Multicenter Study in Tertiary-Care Centers in Jakarta.Annals of global health · 2023Article
- Knowledge of Chronic Kidney Disease among the General Population: A Questionnaire Survey in Hokkaido Prefecture, Japan.Journal of personalized medicine · 2022Article
- Article
- Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2022Article
- Environmental Impact of Care for End-stage Kidney Disease on the Earth and Humans.JMA journal · 2022Article
- Dialysis Care around the World: A Global Perspectives Series.Kidney360 · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.